These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Limitations of successful photocoagulation in proliferative diabetic retinopathy. Freyler H; Klemen U; Egerer I Mod Probl Ophthalmol; 1979; 20():396-400. PubMed ID: 95031 [No Abstract] [Full Text] [Related]
14. [Indications for suppressive pituitary interstitial stereogammatherapy in diabetic retinopathy]. Constantinides G; Vanhullebusch A; Jounda M; Lenski C Bull Soc Ophtalmol Fr; 1985 Feb; 85(2):195-8. PubMed ID: 3910291 [No Abstract] [Full Text] [Related]
15. [Panphotocoagulation in simple and proliferative diabetic retinopathy]. Mirkiewicz-Sieradzka B; Romanowska B; Zygulska-Machowa H Klin Oczna; 1988 Sep; 90(9):317-9. PubMed ID: 2469824 [No Abstract] [Full Text] [Related]
16. Time span of regression or disappearance of optic disk neovascularisation in proliferative diabetic retinopathy after panretinal argon laser photocoagulation and results over a two-year follow-up. Theodossiadis GP; Ismiridis KJ Fortschr Ophthalmol; 1987; 84(5):465-7. PubMed ID: 2448214 [No Abstract] [Full Text] [Related]
17. [Long-term results of stereoghif in diabetic retinopathy]. Malthieu D; Constantinides G; Turut P Bull Soc Ophtalmol Fr; 1990; 90(8-9):767, 770-3. PubMed ID: 2257651 [No Abstract] [Full Text] [Related]